Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
- Author:
Hyun Cheol CHUNG
1
;
Jae Kyung ROH
;
Yong Joon PARK
;
Sang In LEE
;
Jin Sik MIN
;
Jong Tae LEE
;
Ki Byum LEE
;
Byung Soo KIM
Author Information
- Publication Type:Case Report
- Keywords: Neoadjuvant chemotherapy; FADE regimen
- MeSH: Adenocarcinoma/*drug therapy/radiography; Antineoplastic Combined Chemotherapy Protocols/*therapeutic use; Case Report; Cisplatin/*administration & dosage; Combined Modality Therapy; Doxorubicin/*administration & dosage; Etoposide/*administration & dosage; Fluorouracil/*administration & dosage; Human; Male; Middle Age; Stomach/pathology/radiography; Stomach Neoplasms/drug therapy/radiography/*surgery; Tomography, X-Ray Computed
- From:Yonsei Medical Journal 1990;31(1):74-79
- CountryRepublic of Korea
- Language:English
- Abstract: The prognosis of unresectable advanced gastric cancer is extremely poor. We tried a neoadjuvant chemotherapy in locally advanced unresectable stomach cancer diagnosed by initial explo-laparotomy. After chemotherapy with the FADE regimen (5-fluorouracil + adriamycin + cisplatin + etoposide), the patient was diagnosed clinically as a complete response state on re-staging with radiological gastrointestinal study, fiber-gastroscopy and computerized tomography. During the second-look operation, the advanced cancer was completely resected and the pathological diagnosis was early gastric cancer (EGC) type IIc, stage II (T1N2Mo).
